Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN1A | P35498 | 1/20 | 0.35 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.35 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2456181 | 0.82 | MAPK1 (0.36) | SCN1ASCN2ASCN3AKMT2APLA2G1B | |
| SCHEMBL2016329 | 0.80 | KMT2A (0.38) | SCN1ASCN2ASCN3AKMT2APLA2G1B | |
| SCHEMBL18507946 | 0.78 | SCN1A (0.33) | SCN1ASCN2ASCN3AKMT2APLA2G1B | |
| SCHEMBL18507948 | 0.78 | LMNA (0.41) | SCN1ASCN2ASCN3AKMT2APLA2G1B | |
| SCHEMBL10407571 | 0.78 | SCN1A (0.33) | SCN1ASCN2ASCN3AKMT2APLA2G1B | |
| SCHEMBL17475504 | 0.76 | SCN1A (0.33) | SCN1ASCN2ASCN3AKMT2APLA2G1B | |
| SCHEMBL17475527 | 0.76 | SCN1A (0.33) | SCN1ASCN2ASCN3AKMT2APLA2G1B | |
| SCHEMBL18652679 | 0.76 | SCN1A (0.33) | SCN1ASCN2ASCN3AKMT2APLA2G1B | |
| SCHEMBL18502210 | 0.74 | — | — | |
| SCHEMBL18502215 | 0.74 | PIK3CD (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170044188-A1 | COPPER COMPOUND, STARTING MATERIAL FOR FORMING THIN FILM, AND METHOD FOR MANUFACTURING THIN FILM | ADEKA CORPORATION (JP) | 2017-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170044188-A1 | COPPER COMPOUND, STARTING MATERIAL FOR FORMING THIN FILM, AND METHOD FOR MANUFACTURING THIN FILM | C5, C9, C1R | SCN1A 2576/4885SCN2A 3793/4885SCN3A 3546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.